AdvaMed® Advancements: Q1 2025 Report
AdvaMed’s Q1 2025 report focuses on tariffs, policy action, and how we’re protecting Medtech innovation.
Emerging Policy Response Resources
2025 Emerging Policy Response Resources
AdvaMed® Statement on President’s Reciprocal Tariff Pause
WASHINGTON – Today AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker:
Amendment To Reciprocal Tariffs and Updated Duties as Applied to Low-Value Imports from The People’s Republic of China
Details a sweeping tariff hike to 84% on Chinese imports and de minimis increases, aiming to protect U.S. economic and national security.
AdvaMed® Statement on Today’s Tariff Announcement
Washington, D.C.– AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker: “Our country is the birthplace of the medical device and technology industry and leads the…
Health Care Organizations on Concerns & Exemptions Regarding Tariffs
Tariffs on medical goods threaten healthcare costs, access, and supply chains. Leading health groups urge exemptions to safeguard patient care.
The Impact of Tariffs on Patient Access to Medical Technology
Tariffs on medtech could disrupt supply chains, increase costs, and delay care. Exemptions are needed to protect hospitals, patients, and innovation.
Make America Healthy Again Fact Sheet
An overview of the Make America Healthy Again Commission, its mission to address chronic disease in the U.S., and policy initiatives aimed at improving public health.
Reciprocal Tariffs Fact Sheet
A breakdown of the administration’s trade policy, highlighting key areas where the U.S. seeks to level the playing field with trading partners through reciprocal tariffs.
2025 Reciprocal Tariffs and Trade
A policy memorandum outlining the administration’s strategy for fair and reciprocal trade, addressing tariff imbalances and protecting American industries.
FAQs: President Trump’s Tariffs on Mexico, Canada, and China
Get clear answers on the scope, impact, and implementation of tariffs on key U.S. trade partners. These FAQs explains tariff rates, exemptions, economic implications, and potential retaliatory actions.